All insights · Surgical Value

More Surgical Volume Does Not Automatically Create More Value

Growth in cases is the easiest number to manage and the least informative about what a surgical operation is worth.

By ONE AXIS · 2026-10 · 6 min read

Executive tension

Surgical volume is the number every board understands. It grows, revenue grows, the case for the new tower writes itself. In most hospitals, volume is the de facto proxy for the health of the surgical business.

Why that can be wrong

Volume measures activity, not value. Two hospitals with the same number of hip replacements can have a three-fold difference in bed-days consumed, a two-fold difference in ICU use and opposite economics under the same commercial agreement. When the extra case arrives, it lands on a pathway that already leaks value — and the leak scales with it. More volume on a leaking pathway produces more leakage, more occupancy pressure and, often, a lower contribution per constrained resource.

ONE AXIS reframe

The question is not how many cases, but how much value per case and per unit of constrained capacity — and who captures it. Value is created along the journey, from the decision for surgery to recovery, and it is measured on one axis: clinical outcome, flow and economics together. Volume is an input to that calculation, not its result.

Framework

Read any surgical line through four lenses before adding volume to it. Outcome: complications, readmission, reoperation, patient-reported function, with denominators. Flow: length of stay, ICU and PACU use, discharge timing, variation between surgeons. Economics: contribution per episode and per bed-day, by payer and contract. Capacity: what the line consumes, what it would release if it performed at its own best, and what management would do with that. A line that scores well on the first three and releases capacity is a line worth growing. A line that leaks is a line worth fixing first.

Executive implication

Ask, for your highest-volume pathway: if volume rose 20 % tomorrow, what would break first — beds, ICU, the operating schedule, the margin? If the answer is 'nothing', you have measured it. If the answer is a guess, the pathway is being managed on volume alone.

Measurement consequence

Volume should be reported next to contribution per constrained unit of capacity — per bed-day, per ICU-day, per operating-room hour — and next to the variation behind the average. Without those two columns, the volume figure is decorative.

Closing question

Which surgical pathway creates the greatest margin per constrained unit of capacity in your institution — and how confidently can you prove it?

Selected evidence

In a prior founder-led hip arthroplasty programme in a large private hospital, net margin per occupied bed-day rose from R$ 1,984 to R$ 6,804. (Claims Registry HIP-003; derived calculation, prior experience, not an ONE AXIS client outcome.)

Executive Conversation